Wegovy a higher-dose semaglutide product from Novo Nordisk is the version approved for chronic weight management in Canada
A: According to ro.co , eligibility requirements include: Age 18+ (some services may require 21+) Resident of state where Ro operates weight loss services BMI 30 (obesity) OR BMI 27 (overweight) with at least one weight-related condition No personal or family history of medullary thyroid carcinoma (MTC) No Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Not pregnant, planning pregnancy within 2 months, or breastfeeding No contraindications for GLP-1 medications Provider approval required based on comprehensive medical evaluation Meeting basic eligibility doesn't guarantee medication approval
The journey of semaglutide highlights how deep science translates into real patient impact
If still not working, call NovoCare support at 1-844-373-0987 while at the pharmacy
Home Health Public Health Generic Ozempic is now about $100 a month
F., Bergman, B., Liu, B., Cui, X., & Brown, K